A group of hackers, named CCP Unmasked, have unearthed the extent of surveillance by the Chinese government on its people
Reports of North Korean leader Kim Jong-Un's ill health have resurfaced, this time from Chang Song-min the former aide to South Korea's late president Kim Dae-Jung. The report suggests that Kim's sister, Kim Yo Jong is set to take over reins of the country
In the wake of the Covid-19 pandemic, IIT-Bombay held a virtual convocation for its graduating students, creating 3D avatars of graduating students receiving their degrees
More than 300 Congress leaders have written to Gandhi, including Kapil Sibal, Manish Tewari, Shashi Tharoor and Ghulam Nabi Azad, saying the party needs active leadership to take on the BJP
The billionaire industrialist said that space may become the next gold rush for government and business owners
The United States has approved 95.5 percent of the total H-1B visa applications filed in the third quarter of this fiscal year. This approval rate is the highest since President Donald Trump came to power
US private equity firm Carlyle has almost finalised a deal to invest around Rs 5,000 crore in Axis Bank through a preferential allotment
Owing to poor sales and no visibility for future demand, the firm has reportedly approached a few automakers soliciting a possible outsourcing deal using its leased assembly facility at Bawal in Haryana
Caller identification app Truecaller on Wednesday said it identified 29.7 billion spam calls and 8.5 billion spam SMS for its users in India last year
Reliance Industries (RIL) announced the acquisition of a 60 per cent stake in online pharmacy company Netmeds' parent company in Vitalic Health for Rs 620 crore valuing it at Rs 1,000 crore. The acquisition gives RIL's retail unit Reliance Retail entry into a vertical e-commerce space, in addition to its online grocery platform JioMart
The Indian govt has kickstarted talks on the roadmap for COVID-19 vaccine production in India, but is yet to strike a pre-production deal. Here's a look at all the Indian vaccines that are in trial in addition to the Oxford vaccine's trials that are being conducted by the Serum Institute